

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 4.65868646 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.65868646 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 4.36760862 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.36760862 |
| 5 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.26954827 |
| 6 | glyoxylate metabolic process (GO:0046487) | 4.25687104 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 4.13213182 |
| 8 | low-density lipoprotein particle remodeling (GO:0034374) | 3.95162812 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 3.78912939 |
| 10 | regulation of cholesterol esterification (GO:0010872) | 3.78615499 |
| 11 | regulation of apoptotic cell clearance (GO:2000425) | 3.78321675 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.75587120 |
| 13 | bile acid biosynthetic process (GO:0006699) | 3.58029538 |
| 14 | lysine catabolic process (GO:0006554) | 3.56236900 |
| 15 | lysine metabolic process (GO:0006553) | 3.56236900 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 3.53523708 |
| 17 | regulation of cholesterol storage (GO:0010885) | 3.52932384 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 3.51555092 |
| 19 | cysteine metabolic process (GO:0006534) | 3.50061836 |
| 20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.49215749 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.46067277 |
| 22 | protein carboxylation (GO:0018214) | 3.46067277 |
| 23 | acetyl-CoA metabolic process (GO:0006084) | 3.45219918 |
| 24 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.38208770 |
| 25 | fatty acid beta-oxidation (GO:0006635) | 3.35426246 |
| 26 | positive regulation of lipid storage (GO:0010884) | 3.34406378 |
| 27 | homocysteine metabolic process (GO:0050667) | 3.31623257 |
| 28 | kynurenine metabolic process (GO:0070189) | 3.31302662 |
| 29 | regulation of protein activation cascade (GO:2000257) | 3.31134372 |
| 30 | intestinal cholesterol absorption (GO:0030299) | 3.30275705 |
| 31 | complement activation, alternative pathway (GO:0006957) | 3.30255764 |
| 32 | regulation of fibrinolysis (GO:0051917) | 3.29958490 |
| 33 | plasma lipoprotein particle assembly (GO:0034377) | 3.29156820 |
| 34 | myelination in peripheral nervous system (GO:0022011) | 3.27730563 |
| 35 | peripheral nervous system axon ensheathment (GO:0032292) | 3.27730563 |
| 36 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.25673806 |
| 37 | protein-lipid complex assembly (GO:0065005) | 3.25052535 |
| 38 | amino-acid betaine metabolic process (GO:0006577) | 3.22545270 |
| 39 | desmosome organization (GO:0002934) | 3.20103257 |
| 40 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.19678678 |
| 41 | plasma lipoprotein particle clearance (GO:0034381) | 3.19330754 |
| 42 | fatty acid oxidation (GO:0019395) | 3.16248766 |
| 43 | cholesterol efflux (GO:0033344) | 3.15398728 |
| 44 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.15252090 |
| 45 | regulation of complement activation (GO:0030449) | 3.14745533 |
| 46 | high-density lipoprotein particle remodeling (GO:0034375) | 3.13616052 |
| 47 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.12696079 |
| 48 | lipid oxidation (GO:0034440) | 3.11002841 |
| 49 | indolalkylamine catabolic process (GO:0046218) | 3.10973716 |
| 50 | tryptophan catabolic process (GO:0006569) | 3.10973716 |
| 51 | indole-containing compound catabolic process (GO:0042436) | 3.10973716 |
| 52 | fatty acid elongation (GO:0030497) | 3.10634400 |
| 53 | plasma lipoprotein particle organization (GO:0071827) | 3.09093826 |
| 54 | protein-lipid complex subunit organization (GO:0071825) | 3.08071064 |
| 55 | bile acid metabolic process (GO:0008206) | 3.07699643 |
| 56 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.07498834 |
| 57 | serine family amino acid catabolic process (GO:0009071) | 3.07448879 |
| 58 | regulation of cardioblast differentiation (GO:0051890) | 3.07193314 |
| 59 | regulation of triglyceride catabolic process (GO:0010896) | 3.04608849 |
| 60 | very long-chain fatty acid metabolic process (GO:0000038) | 3.04082773 |
| 61 | negative regulation of hemostasis (GO:1900047) | 3.03081962 |
| 62 | negative regulation of blood coagulation (GO:0030195) | 3.03081962 |
| 63 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.02136291 |
| 64 | blood coagulation, intrinsic pathway (GO:0007597) | 3.01089919 |
| 65 | fatty acid catabolic process (GO:0009062) | 3.00967676 |
| 66 | linoleic acid metabolic process (GO:0043651) | 3.00765368 |
| 67 | triglyceride homeostasis (GO:0070328) | 2.99907017 |
| 68 | acylglycerol homeostasis (GO:0055090) | 2.99907017 |
| 69 | short-chain fatty acid metabolic process (GO:0046459) | 2.98027875 |
| 70 | fatty acid transmembrane transport (GO:1902001) | 2.97898811 |
| 71 | acute-phase response (GO:0006953) | 2.97811898 |
| 72 | fibrinolysis (GO:0042730) | 2.97747833 |
| 73 | cellular glucuronidation (GO:0052695) | 2.96740004 |
| 74 | tryptophan metabolic process (GO:0006568) | 2.96541798 |
| 75 | ovulation from ovarian follicle (GO:0001542) | 2.96056265 |
| 76 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.95309966 |
| 77 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.95197568 |
| 78 | negative regulation of lipase activity (GO:0060192) | 2.94874814 |
| 79 | acrosome reaction (GO:0007340) | 2.93623447 |
| 80 | positive regulation of fatty acid oxidation (GO:0046321) | 2.93145481 |
| 81 | reverse cholesterol transport (GO:0043691) | 2.92008966 |
| 82 | negative regulation of cholesterol transport (GO:0032375) | 2.90974120 |
| 83 | negative regulation of sterol transport (GO:0032372) | 2.90974120 |
| 84 | monocarboxylic acid catabolic process (GO:0072329) | 2.90155065 |
| 85 | diacylglycerol metabolic process (GO:0046339) | 2.89869810 |
| 86 | cellular ketone body metabolic process (GO:0046950) | 2.89722081 |
| 87 | regulation of cholesterol homeostasis (GO:2000188) | 2.89675868 |
| 88 | urea cycle (GO:0000050) | 2.87149569 |
| 89 | urea metabolic process (GO:0019627) | 2.87149569 |
| 90 | 2-oxoglutarate metabolic process (GO:0006103) | 2.85097798 |
| 91 | carnitine shuttle (GO:0006853) | 2.84278022 |
| 92 | negative regulation of coagulation (GO:0050819) | 2.83901244 |
| 93 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.83618976 |
| 94 | regulation of plasminogen activation (GO:0010755) | 2.82911387 |
| 95 | tyrosine metabolic process (GO:0006570) | 2.79856384 |
| 96 | ethanol oxidation (GO:0006069) | 2.78832917 |
| 97 | alpha-amino acid catabolic process (GO:1901606) | 2.78439530 |
| 98 | positive regulation of steroid metabolic process (GO:0045940) | 2.77625518 |
| 99 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.76018040 |
| 100 | cellular modified amino acid catabolic process (GO:0042219) | 2.75438482 |
| 101 | negative regulation of protein activation cascade (GO:2000258) | 2.74165656 |
| 102 | thioester biosynthetic process (GO:0035384) | 2.73971826 |
| 103 | acyl-CoA biosynthetic process (GO:0071616) | 2.73971826 |
| 104 | acylglycerol catabolic process (GO:0046464) | 2.72036151 |
| 105 | neutral lipid catabolic process (GO:0046461) | 2.72036151 |
| 106 | aspartate family amino acid catabolic process (GO:0009068) | 2.71854613 |
| 107 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.71813372 |
| 108 | carnitine metabolic process (GO:0009437) | 2.71464383 |
| 109 | phospholipid efflux (GO:0033700) | 2.70911809 |
| 110 | positive regulation of heat generation (GO:0031652) | 2.70874959 |
| 111 | sexual reproduction (GO:0019953) | 2.69208300 |
| 112 | positive regulation of blood coagulation (GO:0030194) | 2.69188949 |
| 113 | positive regulation of hemostasis (GO:1900048) | 2.69188949 |
| 114 | regulation of phospholipase A2 activity (GO:0032429) | 2.68895766 |
| 115 | lipoprotein metabolic process (GO:0042157) | 2.68397573 |
| 116 | plasma lipoprotein particle remodeling (GO:0034369) | 2.66641117 |
| 117 | protein-lipid complex remodeling (GO:0034368) | 2.66641117 |
| 118 | macromolecular complex remodeling (GO:0034367) | 2.66641117 |
| 119 | negative regulation of wound healing (GO:0061045) | 2.66595524 |
| 120 | nitrogen cycle metabolic process (GO:0071941) | 2.64316684 |
| 121 | cellular amino acid catabolic process (GO:0009063) | 2.64182382 |
| 122 | acyl-CoA metabolic process (GO:0006637) | 2.63343983 |
| 123 | thioester metabolic process (GO:0035383) | 2.63343983 |
| 124 | phospholipid homeostasis (GO:0055091) | 2.62727904 |
| 125 | positive regulation of lipid catabolic process (GO:0050996) | 2.62584466 |
| 126 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.62375438 |
| 127 | aromatic amino acid family metabolic process (GO:0009072) | 2.62046093 |
| 128 | adhesion of symbiont to host cell (GO:0044650) | 2.61936115 |
| 129 | virion attachment to host cell (GO:0019062) | 2.61936115 |
| 130 | endocardial cushion development (GO:0003197) | 2.61173308 |
| 131 | cholesterol homeostasis (GO:0042632) | 2.60531818 |
| 132 | coenzyme catabolic process (GO:0009109) | 2.60407883 |
| 133 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.59755510 |
| 134 | negative regulation of platelet activation (GO:0010544) | 2.58553745 |
| 135 | uronic acid metabolic process (GO:0006063) | 2.58412704 |
| 136 | glucuronate metabolic process (GO:0019585) | 2.58412704 |
| 137 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.58270961 |
| 138 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.57889885 |
| 139 | regulation of lipoprotein metabolic process (GO:0050746) | 2.57761613 |
| 140 | glutamate metabolic process (GO:0006536) | 2.57657028 |
| 141 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.57598108 |
| 142 | organic acid catabolic process (GO:0016054) | 2.57062447 |
| 143 | carboxylic acid catabolic process (GO:0046395) | 2.57062447 |
| 144 | sterol homeostasis (GO:0055092) | 2.56729597 |
| 145 | low-density lipoprotein particle clearance (GO:0034383) | 2.56606293 |
| 146 | regulation of cholesterol metabolic process (GO:0090181) | 2.54951765 |
| 147 | positive regulation of coagulation (GO:0050820) | 2.53633315 |
| 148 | regulation of fever generation (GO:0031620) | 2.49659434 |
| 149 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.49208015 |
| 150 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.49208015 |
| 151 | response to muscle activity (GO:0014850) | 2.47252741 |
| 152 | negative regulation of lipid transport (GO:0032369) | 2.46665672 |
| 153 | opsonization (GO:0008228) | 2.45705927 |
| 154 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.45455911 |
| 155 | protein activation cascade (GO:0072376) | 2.42953512 |
| 156 | positive regulation of extracellular matrix organization (GO:1903055) | 2.42940272 |
| 157 | regulation of lipid storage (GO:0010883) | 2.41540352 |
| 158 | sperm motility (GO:0030317) | 2.39699668 |
| 159 | triglyceride catabolic process (GO:0019433) | 2.38675403 |
| 160 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.38213417 |
| 161 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.38200492 |
| 162 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.35483085 |
| 163 | cell proliferation involved in metanephros development (GO:0072203) | 2.35150617 |
| 164 | negative regulation of fatty acid transport (GO:2000192) | 2.35040071 |
| 165 | negative regulation of complement activation (GO:0045916) | 2.32773966 |
| 166 | plasma membrane fusion (GO:0045026) | 2.32082134 |
| 167 | intestinal absorption (GO:0050892) | 2.30415145 |
| 168 | apoptotic cell clearance (GO:0043277) | 2.28633315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.04953452 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.27839860 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.21191674 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.01032959 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.70887158 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.70001911 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.12270074 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.92347983 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.69241095 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.65951341 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.31849886 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.30917731 |
| 13 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.10221134 |
| 14 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.03770532 |
| 15 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.99788112 |
| 16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.93171437 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.88197929 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.81136610 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.70031711 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.67479827 |
| 21 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.65272271 |
| 22 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.60718137 |
| 23 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.58178363 |
| 24 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.54837459 |
| 25 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.52944124 |
| 26 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.52300642 |
| 27 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.47507463 |
| 28 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.44448860 |
| 29 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.41221607 |
| 30 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.38579407 |
| 31 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.33124002 |
| 32 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.33124002 |
| 33 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.32009764 |
| 34 | CJUN_26792858_Chip-Seq_BT549_Human | 1.30738230 |
| 35 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.28027017 |
| 36 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.27131400 |
| 37 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.25124639 |
| 38 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.25124639 |
| 39 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.24603081 |
| 40 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.22714989 |
| 41 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.21085794 |
| 42 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.20146059 |
| 43 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18676734 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18204228 |
| 45 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.16666776 |
| 46 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.13395459 |
| 47 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12836501 |
| 48 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12275839 |
| 49 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.11246880 |
| 50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.10887807 |
| 51 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.09858571 |
| 52 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.08682910 |
| 53 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.08291888 |
| 54 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.08121580 |
| 55 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.07827181 |
| 56 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.07164909 |
| 57 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.06108388 |
| 58 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04235442 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03579353 |
| 60 | RXR_22108803_ChIP-Seq_LS180_Human | 1.02454073 |
| 61 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.01541762 |
| 62 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01027039 |
| 63 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.00213095 |
| 64 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.99180736 |
| 65 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.99137354 |
| 66 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.99103133 |
| 67 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.99103133 |
| 68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99035708 |
| 69 | TP53_16413492_ChIP-PET_HCT116_Human | 0.98127032 |
| 70 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97078404 |
| 71 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96815891 |
| 72 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95956421 |
| 73 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94380041 |
| 74 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.93952142 |
| 75 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.93735968 |
| 76 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93336822 |
| 77 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92911616 |
| 78 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.92911616 |
| 79 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.92069262 |
| 80 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.91775182 |
| 81 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.91637256 |
| 82 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.91163538 |
| 83 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.90605675 |
| 84 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90605520 |
| 85 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90228457 |
| 86 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90024154 |
| 87 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.89094835 |
| 88 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88767325 |
| 89 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.88766556 |
| 90 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.88265915 |
| 91 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.88260543 |
| 92 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87324609 |
| 93 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87217318 |
| 94 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.86018936 |
| 95 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.85864422 |
| 96 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.84764612 |
| 97 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84753500 |
| 98 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84695965 |
| 99 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84630065 |
| 100 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.83157183 |
| 101 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82681265 |
| 102 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.82516090 |
| 103 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.81477339 |
| 104 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.79927214 |
| 105 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.79526454 |
| 106 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.79464049 |
| 107 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.79213947 |
| 108 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.79137655 |
| 109 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.79087341 |
| 110 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.78806691 |
| 111 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.78498492 |
| 112 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.78309768 |
| 113 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.77971648 |
| 114 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.77901506 |
| 115 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.77479671 |
| 116 | KDM2B_26808549_Chip-Seq_REH_Human | 0.77145372 |
| 117 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.77002914 |
| 118 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76760863 |
| 119 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.76599403 |
| 120 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.75937543 |
| 121 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.75888994 |
| 122 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.75864512 |
| 123 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.75372370 |
| 124 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.74993662 |
| 125 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.74799725 |
| 126 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.74691972 |
| 127 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.73654418 |
| 128 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.73507907 |
| 129 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.73507907 |
| 130 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.73497978 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.47612997 |
| 2 | MP0005360_urolithiasis | 4.35090412 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.49745123 |
| 4 | MP0005365_abnormal_bile_salt | 3.30041093 |
| 5 | MP0005410_abnormal_fertilization | 3.27621389 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.76240246 |
| 7 | MP0005275_abnormal_skin_tensile | 2.75368220 |
| 8 | MP0005167_abnormal_blood-brain_barrier | 2.73957017 |
| 9 | MP0003646_muscle_fatigue | 2.63089831 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.49775862 |
| 11 | MP0003303_peritoneal_inflammation | 2.47339417 |
| 12 | MP0003252_abnormal_bile_duct | 2.46917729 |
| 13 | MP0002796_impaired_skin_barrier | 2.39647052 |
| 14 | MP0008438_abnormal_cutaneous_collagen | 2.33349110 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.28151797 |
| 16 | MP0003195_calcinosis | 2.18110985 |
| 17 | MP0004510_myositis | 2.15386043 |
| 18 | MP0004272_abnormal_basement_membrane | 2.12303465 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.10391934 |
| 20 | MP0002837_dystrophic_cardiac_calcinosis | 2.05164686 |
| 21 | MP0005332_abnormal_amino_acid | 1.86622134 |
| 22 | MP0009384_cardiac_valve_regurgitation | 1.83061122 |
| 23 | MP0004084_abnormal_cardiac_muscle | 1.79352943 |
| 24 | MP0003011_delayed_dark_adaptation | 1.78149849 |
| 25 | MP0004185_abnormal_adipocyte_glucose | 1.69553827 |
| 26 | MP0005451_abnormal_body_composition | 1.66919497 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.65224503 |
| 28 | MP0002254_reproductive_system_inflammat | 1.62330953 |
| 29 | MP0001666_abnormal_nutrient_absorption | 1.61813006 |
| 30 | MP0004130_abnormal_muscle_cell | 1.59707884 |
| 31 | MP0005023_abnormal_wound_healing | 1.59077910 |
| 32 | MP0005670_abnormal_white_adipose | 1.58738282 |
| 33 | MP0000579_abnormal_nail_morphology | 1.57738720 |
| 34 | MP0003690_abnormal_glial_cell | 1.56476473 |
| 35 | MP0005666_abnormal_adipose_tissue | 1.55971595 |
| 36 | MP0003950_abnormal_plasma_membrane | 1.51577572 |
| 37 | MP0010368_abnormal_lymphatic_system | 1.50696170 |
| 38 | MP0009840_abnormal_foam_cell | 1.49464390 |
| 39 | MP0004036_abnormal_muscle_relaxation | 1.48353006 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.46478031 |
| 41 | MP0002089_abnormal_postnatal_growth/wei | 1.45384111 |
| 42 | MP0002118_abnormal_lipid_homeostasis | 1.44882536 |
| 43 | MP0001661_extended_life_span | 1.44054576 |
| 44 | MP0003941_abnormal_skin_development | 1.43265797 |
| 45 | MP0005330_cardiomyopathy | 1.41811311 |
| 46 | MP0002060_abnormal_skin_morphology | 1.41715498 |
| 47 | MP0000751_myopathy | 1.39339774 |
| 48 | MP0005058_abnormal_lysosome_morphology | 1.37118645 |
| 49 | MP0004019_abnormal_vitamin_homeostasis | 1.34826496 |
| 50 | MP0000604_amyloidosis | 1.33935446 |
| 51 | MP0009115_abnormal_fat_cell | 1.32650782 |
| 52 | MP0005409_darkened_coat_color | 1.27053733 |
| 53 | MP0006054_spinal_hemorrhage | 1.25794297 |
| 54 | MP0005503_abnormal_tendon_morphology | 1.25564911 |
| 55 | MP0005257_abnormal_intraocular_pressure | 1.25020268 |
| 56 | MP0010234_abnormal_vibrissa_follicle | 1.23646366 |
| 57 | MP0009053_abnormal_anal_canal | 1.22895006 |
| 58 | MP0000467_abnormal_esophagus_morphology | 1.22098931 |
| 59 | MP0000647_abnormal_sebaceous_gland | 1.22083707 |
| 60 | MP0005164_abnormal_response_to | 1.22038475 |
| 61 | MP0003566_abnormal_cell_adhesion | 1.21343199 |
| 62 | MP0005501_abnormal_skin_physiology | 1.20791980 |
| 63 | MP0002108_abnormal_muscle_morphology | 1.19339056 |
| 64 | MP0010678_abnormal_skin_adnexa | 1.18349988 |
| 65 | MP0005408_hypopigmentation | 1.17969492 |
| 66 | MP0003075_altered_response_to | 1.17420907 |
| 67 | MP0005595_abnormal_vascular_smooth | 1.16883501 |
| 68 | MP0005623_abnormal_meninges_morphology | 1.16566521 |
| 69 | MP0006138_congestive_heart_failure | 1.15701994 |
| 70 | MP0001915_intracranial_hemorrhage | 1.14375239 |
| 71 | MP0000762_abnormal_tongue_morphology | 1.13934112 |
| 72 | MP0000383_abnormal_hair_follicle | 1.12915392 |
| 73 | MP0005375_adipose_tissue_phenotype | 1.12319431 |
| 74 | MP0000749_muscle_degeneration | 1.11654325 |
| 75 | MP0003172_abnormal_lysosome_physiology | 1.10503959 |
| 76 | MP0005083_abnormal_biliary_tract | 1.10265696 |
| 77 | MP0000566_synostosis | 1.08926906 |
| 78 | MP0008004_abnormal_stomach_pH | 1.08734491 |
| 79 | MP0008775_abnormal_heart_ventricle | 1.07564842 |
| 80 | MP0002332_abnormal_exercise_endurance | 1.06935170 |
| 81 | MP0002098_abnormal_vibrissa_morphology | 1.06865284 |
| 82 | MP0004087_abnormal_muscle_fiber | 1.04139112 |
| 83 | MP0003879_abnormal_hair_cell | 0.99853336 |
| 84 | MP0005620_abnormal_muscle_contractility | 0.99201591 |
| 85 | MP0004215_abnormal_myocardial_fiber | 0.98639724 |
| 86 | MP0002972_abnormal_cardiac_muscle | 0.98016644 |
| 87 | MP0009643_abnormal_urine_homeostasis | 0.97886556 |
| 88 | MP0000609_abnormal_liver_physiology | 0.97443934 |
| 89 | MP0000767_abnormal_smooth_muscle | 0.97196177 |
| 90 | MP0004484_altered_response_of | 0.96093732 |
| 91 | MP0002295_abnormal_pulmonary_circulatio | 0.96063740 |
| 92 | MP0000462_abnormal_digestive_system | 0.94738503 |
| 93 | MP0004134_abnormal_chest_morphology | 0.94196326 |
| 94 | MP0000343_altered_response_to | 0.93448964 |
| 95 | MP0005319_abnormal_enzyme/_coenzyme | 0.93382189 |
| 96 | MP0010030_abnormal_orbit_morphology | 0.92720428 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.92117898 |
| 98 | MP0001501_abnormal_sleep_pattern | 0.91661536 |
| 99 | MP0003868_abnormal_feces_composition | 0.91029431 |
| 100 | MP0005334_abnormal_fat_pad | 0.90736831 |
| 101 | MP0010630_abnormal_cardiac_muscle | 0.89898351 |
| 102 | MP0003329_amyloid_beta_deposits | 0.89751436 |
| 103 | MP0003279_aneurysm | 0.89670559 |
| 104 | MP0002282_abnormal_trachea_morphology | 0.88901653 |
| 105 | MP0003091_abnormal_cell_migration | 0.88386050 |
| 106 | MP0000427_abnormal_hair_cycle | 0.87949106 |
| 107 | MP0000920_abnormal_myelination | 0.86288886 |
| 108 | MP0002269_muscular_atrophy | 0.86225441 |
| 109 | MP0000013_abnormal_adipose_tissue | 0.85958920 |
| 110 | MP0000537_abnormal_urethra_morphology | 0.85939078 |
| 111 | MP0000249_abnormal_blood_vessel | 0.85615927 |
| 112 | MP0005647_abnormal_sex_gland | 0.84468743 |
| 113 | MP0003633_abnormal_nervous_system | 0.84169498 |
| 114 | MP0001544_abnormal_cardiovascular_syste | 0.84167823 |
| 115 | MP0005385_cardiovascular_system_phenoty | 0.84167823 |
| 116 | MP0002168_other_aberrant_phenotype | 0.84050540 |
| 117 | MP0005448_abnormal_energy_balance | 0.83849314 |
| 118 | MP0002933_joint_inflammation | 0.83724214 |
| 119 | MP0002998_abnormal_bone_remodeling | 0.83557897 |
| 120 | MP0009250_abnormal_appendicular_skeleto | 0.83180143 |
| 121 | MP0000747_muscle_weakness | 0.82968411 |
| 122 | MP0003878_abnormal_ear_physiology | 0.82708706 |
| 123 | MP0005377_hearing/vestibular/ear_phenot | 0.82708706 |
| 124 | MP0001879_abnormal_lymphatic_vessel | 0.81278991 |
| 125 | MP0003122_maternal_imprinting | 0.81173281 |
| 126 | MP0005379_endocrine/exocrine_gland_phen | 0.80863969 |
| 127 | MP0002971_abnormal_brown_adipose | 0.80740653 |
| 128 | MP0002896_abnormal_bone_mineralization | 0.80173124 |
| 129 | MP0000003_abnormal_adipose_tissue | 0.79561649 |
| 130 | MP0001216_abnormal_epidermal_layer | 0.77746652 |
| 131 | MP0005165_increased_susceptibility_to | 0.77656047 |
| 132 | MP0009780_abnormal_chondrocyte_physiolo | 0.77564195 |
| 133 | MP0002106_abnormal_muscle_physiology | 0.77462886 |
| 134 | MP0005166_decreased_susceptibility_to | 0.75557475 |
| 135 | MP0005535_abnormal_body_temperature | 0.74915104 |
| 136 | MP0001299_abnormal_eye_distance/ | 0.74730562 |
| 137 | MP0003385_abnormal_body_wall | 0.74566925 |
| 138 | MP0002249_abnormal_larynx_morphology | 0.73978720 |
| 139 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.73127243 |
| 140 | MP0000371_diluted_coat_color | 0.72742715 |
| 141 | MP0000377_abnormal_hair_follicle | 0.72355021 |
| 142 | MP0010771_integument_phenotype | 0.72324755 |
| 143 | MP0004381_abnormal_hair_follicle | 0.72302584 |
| 144 | MP0000163_abnormal_cartilage_morphology | 0.71401309 |
| 145 | MP0009764_decreased_sensitivity_to | 0.70829033 |
| 146 | MP0004145_abnormal_muscle_electrophysio | 0.70418329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 4.82752666 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.59807821 |
| 3 | Glomerulonephritis (HP:0000099) | 4.30613691 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 4.15282780 |
| 5 | Xanthomatosis (HP:0000991) | 4.15103467 |
| 6 | Right ventricular cardiomyopathy (HP:0011663) | 4.12058245 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 3.59952585 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.57091296 |
| 9 | Potter facies (HP:0002009) | 3.53062112 |
| 10 | Facial shape deformation (HP:0011334) | 3.53062112 |
| 11 | Asymmetric septal hypertrophy (HP:0001670) | 3.50420211 |
| 12 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.45692642 |
| 13 | Epidermoid cyst (HP:0200040) | 3.27404988 |
| 14 | Hyperglycinuria (HP:0003108) | 3.23911678 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 3.20667862 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 3.17106927 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.10826593 |
| 18 | Abnormality of glycine metabolism (HP:0010895) | 3.10826593 |
| 19 | Complement deficiency (HP:0004431) | 3.04079401 |
| 20 | Hypoglycemic coma (HP:0001325) | 3.04024276 |
| 21 | Ketosis (HP:0001946) | 2.89019090 |
| 22 | Prolonged partial thromboplastin time (HP:0003645) | 2.88242844 |
| 23 | Hyperglycinemia (HP:0002154) | 2.80591396 |
| 24 | Hypolipoproteinemia (HP:0010981) | 2.79182375 |
| 25 | Hyperammonemia (HP:0001987) | 2.76595940 |
| 26 | Muscle fiber splitting (HP:0003555) | 2.75129047 |
| 27 | Nephritis (HP:0000123) | 2.71426148 |
| 28 | Hypobetalipoproteinemia (HP:0003563) | 2.69796797 |
| 29 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.69304868 |
| 30 | Bundle branch block (HP:0011710) | 2.67400890 |
| 31 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.67386780 |
| 32 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.67379316 |
| 33 | Sudden death (HP:0001699) | 2.64830467 |
| 34 | Ketoacidosis (HP:0001993) | 2.62467112 |
| 35 | Small epiphyses (HP:0010585) | 2.56533728 |
| 36 | Spontaneous abortion (HP:0005268) | 2.55799093 |
| 37 | Broad metatarsal (HP:0001783) | 2.55329871 |
| 38 | Pigmentary retinal degeneration (HP:0001146) | 2.52241261 |
| 39 | Ventricular tachycardia (HP:0004756) | 2.51482734 |
| 40 | Increased connective tissue (HP:0009025) | 2.47357512 |
| 41 | Lymphangioma (HP:0100764) | 2.46929802 |
| 42 | Abnormality of the nasal septum (HP:0000419) | 2.45962123 |
| 43 | Vascular calcification (HP:0004934) | 2.35724560 |
| 44 | Abnormal cartilage morphology (HP:0002763) | 2.34508158 |
| 45 | Widely patent fontanelles and sutures (HP:0004492) | 2.34241062 |
| 46 | Cardiovascular calcification (HP:0011915) | 2.34076050 |
| 47 | Abnormality of carpal bone ossification (HP:0006257) | 2.34047236 |
| 48 | Hypoplastic ischia (HP:0003175) | 2.33181474 |
| 49 | Abnormality of the common coagulation pathway (HP:0010990) | 2.32509506 |
| 50 | Premature rupture of membranes (HP:0001788) | 2.31677186 |
| 51 | Abnormality of the ischium (HP:0003174) | 2.31418461 |
| 52 | Myoglobinuria (HP:0002913) | 2.30661200 |
| 53 | Neurofibrillary tangles (HP:0002185) | 2.26941518 |
| 54 | Fat malabsorption (HP:0002630) | 2.26899141 |
| 55 | Turricephaly (HP:0000262) | 2.25561654 |
| 56 | Flared iliac wings (HP:0002869) | 2.25224374 |
| 57 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.23625799 |
| 58 | Epiphyseal dysplasia (HP:0002656) | 2.23592471 |
| 59 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.23231486 |
| 60 | Skin nodule (HP:0200036) | 2.22385456 |
| 61 | Abnormality of the intrinsic pathway (HP:0010989) | 2.20790123 |
| 62 | Exercise-induced myalgia (HP:0003738) | 2.20306758 |
| 63 | Hypophosphatemic rickets (HP:0004912) | 2.17167553 |
| 64 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.15864712 |
| 65 | Nuclear cataract (HP:0100018) | 2.13347939 |
| 66 | Hemorrhage of the eye (HP:0011885) | 2.12934149 |
| 67 | Atrial fibrillation (HP:0005110) | 2.11709530 |
| 68 | Vitreoretinal degeneration (HP:0000655) | 2.10629237 |
| 69 | Delayed CNS myelination (HP:0002188) | 2.06387524 |
| 70 | Hydroxyprolinuria (HP:0003080) | 2.05521602 |
| 71 | Abnormality of proline metabolism (HP:0010907) | 2.05521602 |
| 72 | Hamartoma of the eye (HP:0010568) | 2.04885427 |
| 73 | Abnormality of complement system (HP:0005339) | 2.04229171 |
| 74 | Coronal craniosynostosis (HP:0004440) | 2.03952071 |
| 75 | Abnormality of methionine metabolism (HP:0010901) | 2.03654201 |
| 76 | Protuberant abdomen (HP:0001538) | 2.02712862 |
| 77 | Hypotrichosis (HP:0001006) | 2.01583232 |
| 78 | Portal hypertension (HP:0001409) | 1.99736864 |
| 79 | Focal segmental glomerulosclerosis (HP:0000097) | 1.95204582 |
| 80 | Abnormal hand bone ossification (HP:0010660) | 1.92249071 |
| 81 | Metaphyseal cupping (HP:0003021) | 1.91537687 |
| 82 | Dicarboxylic aciduria (HP:0003215) | 1.91413203 |
| 83 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.91413203 |
| 84 | Retinal atrophy (HP:0001105) | 1.90234846 |
| 85 | Osteomalacia (HP:0002749) | 1.89201526 |
| 86 | Syncope (HP:0001279) | 1.89125880 |
| 87 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.88814241 |
| 88 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.88814241 |
| 89 | Abnormality of glycolipid metabolism (HP:0010969) | 1.88814241 |
| 90 | Acanthosis nigricans (HP:0000956) | 1.87296625 |
| 91 | Abnormal ossification of hand bones (HP:0005921) | 1.87047447 |
| 92 | Hypercholesterolemia (HP:0003124) | 1.86416973 |
| 93 | Type 1 muscle fiber predominance (HP:0003803) | 1.86065313 |
| 94 | Mitral stenosis (HP:0001718) | 1.85928678 |
| 95 | Hypoglycemic seizures (HP:0002173) | 1.85862207 |
| 96 | Aortic aneurysm (HP:0004942) | 1.85457918 |
| 97 | Exercise-induced muscle cramps (HP:0003710) | 1.84290920 |
| 98 | Abnormal tarsal ossification (HP:0008369) | 1.83516196 |
| 99 | Amyloidosis (HP:0011034) | 1.83384398 |
| 100 | Primary atrial arrhythmia (HP:0001692) | 1.82845202 |
| 101 | Cerebral aneurysm (HP:0004944) | 1.82677504 |
| 102 | Generalized aminoaciduria (HP:0002909) | 1.80809350 |
| 103 | Ovoid vertebral bodies (HP:0003300) | 1.80500670 |
| 104 | Abnormal atrioventricular conduction (HP:0005150) | 1.79698827 |
| 105 | Abnormality of the hepatic vasculature (HP:0006707) | 1.79191850 |
| 106 | Arthropathy (HP:0003040) | 1.78883258 |
| 107 | Heart block (HP:0012722) | 1.78358314 |
| 108 | Mucopolysacchariduria (HP:0008155) | 1.78229313 |
| 109 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.78229313 |
| 110 | Abnormality of the parathyroid morphology (HP:0011766) | 1.77949624 |
| 111 | Scapular winging (HP:0003691) | 1.77897758 |
| 112 | Joint hemorrhage (HP:0005261) | 1.76522043 |
| 113 | Abnormal urine output (HP:0012590) | 1.76260413 |
| 114 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.75955007 |
| 115 | Cerebral inclusion bodies (HP:0100314) | 1.75487281 |
| 116 | Visceral angiomatosis (HP:0100761) | 1.75142905 |
| 117 | Glomerulosclerosis (HP:0000096) | 1.74975631 |
| 118 | Purpura (HP:0000979) | 1.74706498 |
| 119 | Protrusio acetabuli (HP:0003179) | 1.74470740 |
| 120 | Abnormality of purine metabolism (HP:0004352) | 1.74376284 |
| 121 | Neonatal short-limb short stature (HP:0008921) | 1.74310268 |
| 122 | Abnormality of the calf musculature (HP:0001430) | 1.74289861 |
| 123 | Back pain (HP:0003418) | 1.73607795 |
| 124 | Advanced eruption of teeth (HP:0006288) | 1.73521597 |
| 125 | Menorrhagia (HP:0000132) | 1.73029232 |
| 126 | Difficulty running (HP:0009046) | 1.72641801 |
| 127 | Conjugated hyperbilirubinemia (HP:0002908) | 1.71972283 |
| 128 | Lipoatrophy (HP:0100578) | 1.71346598 |
| 129 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.71024146 |
| 130 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.71024146 |
| 131 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.71024146 |
| 132 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.70814274 |
| 133 | Bradycardia (HP:0001662) | 1.69899253 |
| 134 | Abnormality of the wing of the ilium (HP:0011867) | 1.69817038 |
| 135 | Malnutrition (HP:0004395) | 1.69164295 |
| 136 | Mesangial abnormality (HP:0001966) | 1.68903548 |
| 137 | Rickets (HP:0002748) | 1.67902612 |
| 138 | Delayed epiphyseal ossification (HP:0002663) | 1.67201146 |
| 139 | Thick nail (HP:0001805) | 1.67107954 |
| 140 | Cupped ribs (HP:0000887) | 1.67092761 |
| 141 | Myocardial infarction (HP:0001658) | 1.66646940 |
| 142 | Severe visual impairment (HP:0001141) | 1.65528565 |
| 143 | Dysostosis multiplex (HP:0000943) | 1.65407946 |
| 144 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.64284094 |
| 145 | Supraventricular tachycardia (HP:0004755) | 1.62717793 |
| 146 | Calf muscle hypertrophy (HP:0008981) | 1.62252526 |
| 147 | Dilated cardiomyopathy (HP:0001644) | 1.61858685 |
| 148 | Esophageal varix (HP:0002040) | 1.61855168 |
| 149 | Wide anterior fontanel (HP:0000260) | 1.61112116 |
| 150 | Abnormal gallbladder morphology (HP:0012437) | 1.61050423 |
| 151 | Limited hip movement (HP:0008800) | 1.60344631 |
| 152 | Increased variability in muscle fiber diameter (HP:0003557) | 1.60205497 |
| 153 | Relative macrocephaly (HP:0004482) | 1.60143943 |
| 154 | Atrophic scars (HP:0001075) | 1.59493566 |
| 155 | Periauricular skin pits (HP:0100277) | 1.59341732 |
| 156 | Preauricular pit (HP:0004467) | 1.59341732 |
| 157 | Natal tooth (HP:0000695) | 1.59181794 |
| 158 | Neonatal death (HP:0003811) | 1.59147716 |
| 159 | Supraventricular arrhythmia (HP:0005115) | 1.58681137 |
| 160 | Metaphyseal irregularity (HP:0003025) | 1.58500802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 5.15930988 |
| 2 | PRPF4B | 3.77102966 |
| 3 | IRAK3 | 2.75838528 |
| 4 | SIK1 | 2.71521201 |
| 5 | AKT3 | 2.56117656 |
| 6 | STK39 | 2.42283156 |
| 7 | BCKDK | 2.39488609 |
| 8 | EPHB2 | 2.33091564 |
| 9 | TTN | 2.26725387 |
| 10 | EPHB1 | 2.12418751 |
| 11 | TYRO3 | 2.05091755 |
| 12 | WNK4 | 2.03718765 |
| 13 | TRIB3 | 2.01927329 |
| 14 | MET | 2.01399818 |
| 15 | NUAK1 | 1.99127601 |
| 16 | FGFR2 | 1.96979100 |
| 17 | ICK | 1.94766112 |
| 18 | STK38L | 1.90616296 |
| 19 | OBSCN | 1.87664575 |
| 20 | DDR2 | 1.79183903 |
| 21 | MYLK | 1.76549870 |
| 22 | FGFR4 | 1.65073547 |
| 23 | PDGFRA | 1.60515293 |
| 24 | TAOK2 | 1.60008980 |
| 25 | ERN1 | 1.53115973 |
| 26 | GRK7 | 1.51750234 |
| 27 | MST1R | 1.49636757 |
| 28 | MAP3K3 | 1.49404175 |
| 29 | PAK3 | 1.47430750 |
| 30 | TESK1 | 1.45185459 |
| 31 | PTK6 | 1.43832517 |
| 32 | MKNK2 | 1.40805526 |
| 33 | TNIK | 1.38489565 |
| 34 | INSRR | 1.37008772 |
| 35 | TIE1 | 1.36264618 |
| 36 | PKN2 | 1.33152224 |
| 37 | DMPK | 1.31258239 |
| 38 | ROCK1 | 1.28225399 |
| 39 | OXSR1 | 1.27639706 |
| 40 | ACVR1B | 1.22674387 |
| 41 | FER | 1.20845549 |
| 42 | MAP3K11 | 1.20758939 |
| 43 | PHKG1 | 1.20621713 |
| 44 | PHKG2 | 1.20621713 |
| 45 | PIK3CA | 1.15237225 |
| 46 | PTK2 | 1.14806516 |
| 47 | RIPK1 | 1.07812669 |
| 48 | PKN1 | 1.07080397 |
| 49 | PIK3CG | 1.07051871 |
| 50 | LMTK2 | 1.04670853 |
| 51 | STK3 | 1.03452855 |
| 52 | ERBB4 | 1.03312981 |
| 53 | TAOK1 | 1.02692738 |
| 54 | BCR | 1.02461158 |
| 55 | PLK4 | 1.02367136 |
| 56 | FRK | 0.99473108 |
| 57 | STK38 | 0.98845559 |
| 58 | PDGFRB | 0.92927892 |
| 59 | WNK1 | 0.92543080 |
| 60 | MAP3K2 | 0.92316056 |
| 61 | FGFR1 | 0.92287288 |
| 62 | SGK2 | 0.87729660 |
| 63 | EPHA2 | 0.87306192 |
| 64 | ROCK2 | 0.84616802 |
| 65 | MAP2K3 | 0.83688469 |
| 66 | SGK3 | 0.82387614 |
| 67 | GSK3A | 0.81257024 |
| 68 | PDK2 | 0.80132149 |
| 69 | LATS2 | 0.79813665 |
| 70 | ERBB2 | 0.78498902 |
| 71 | MAPKAPK3 | 0.77456993 |
| 72 | PRKD1 | 0.76236725 |
| 73 | BMX | 0.75579100 |
| 74 | PRKAA2 | 0.74547043 |
| 75 | MAPK15 | 0.73368805 |
| 76 | PDK1 | 0.72403083 |
| 77 | EPHA3 | 0.71638719 |
| 78 | PAK2 | 0.71258030 |
| 79 | CAMK1D | 0.69381653 |
| 80 | MAP3K1 | 0.66855442 |
| 81 | CDK12 | 0.66499324 |
| 82 | PDK4 | 0.65347333 |
| 83 | PDK3 | 0.65347333 |
| 84 | TRPM7 | 0.64367659 |
| 85 | ADRBK2 | 0.63792053 |
| 86 | PINK1 | 0.63625526 |
| 87 | PLK2 | 0.62971580 |
| 88 | MATK | 0.62167865 |
| 89 | MUSK | 0.61884857 |
| 90 | EEF2K | 0.61799541 |
| 91 | IRAK1 | 0.61494308 |
| 92 | NLK | 0.61064565 |
| 93 | MTOR | 0.58580107 |
| 94 | MAP3K7 | 0.57540958 |
| 95 | NEK6 | 0.56607640 |
| 96 | MAP3K6 | 0.56334905 |
| 97 | SGK1 | 0.55875716 |
| 98 | WNK3 | 0.53753568 |
| 99 | IRAK2 | 0.52703848 |
| 100 | STK24 | 0.52173697 |
| 101 | MOS | 0.52160267 |
| 102 | FGFR3 | 0.51980005 |
| 103 | FGR | 0.51958479 |
| 104 | TGFBR2 | 0.51523826 |
| 105 | NTRK3 | 0.51123178 |
| 106 | PRKAA1 | 0.50541696 |
| 107 | MAPK11 | 0.50540702 |
| 108 | MAP3K5 | 0.49851978 |
| 109 | CAMK1 | 0.49107741 |
| 110 | CAMK1G | 0.49045599 |
| 111 | DYRK1B | 0.47207520 |
| 112 | CDC42BPA | 0.46618216 |
| 113 | FLT3 | 0.45935002 |
| 114 | MAP4K2 | 0.45926625 |
| 115 | RET | 0.45756254 |
| 116 | CSK | 0.44630065 |
| 117 | PRKCH | 0.44145926 |
| 118 | PRKD2 | 0.42805562 |
| 119 | DAPK2 | 0.42755196 |
| 120 | CHUK | 0.42207422 |
| 121 | MAPK7 | 0.42116545 |
| 122 | MAPK4 | 0.41653608 |
| 123 | ABL2 | 0.40489449 |
| 124 | CAMK2D | 0.40217586 |
| 125 | MAP2K1 | 0.38472139 |
| 126 | GRK1 | 0.38132235 |
| 127 | INSR | 0.37969132 |
| 128 | NTRK1 | 0.37874168 |
| 129 | MST4 | 0.37154313 |
| 130 | PDPK1 | 0.36467222 |
| 131 | SGK223 | 0.35737933 |
| 132 | SGK494 | 0.35737933 |
| 133 | CAMK2G | 0.35466091 |
| 134 | MAPK12 | 0.35295867 |
| 135 | PRKACG | 0.34135300 |
| 136 | NEK9 | 0.33779380 |
| 137 | RPS6KB2 | 0.32695434 |
| 138 | KDR | 0.32506112 |
| 139 | PRKD3 | 0.31939058 |
| 140 | JAK1 | 0.30965944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.22637370 |
| 2 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.91892480 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.66825996 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.61674050 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.61362310 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.50798913 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.49251703 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.46091549 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.34604143 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.29860641 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.20770960 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.20625338 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.19256668 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.18379997 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.14325067 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.12050428 |
| 17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.03310333 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.02699220 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.00741557 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.88048933 |
| 21 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.85832716 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.79240853 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.58199463 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.54468544 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.54053951 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.53602700 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.48737098 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.47708659 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.46401891 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.45875303 |
| 31 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.43668973 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.41981515 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41403413 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.38040225 |
| 35 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.33762548 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.32873585 |
| 37 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.31119246 |
| 38 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.30402866 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.29318862 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.24553402 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.23126166 |
| 42 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.21296054 |
| 43 | Carbon metabolism_Homo sapiens_hsa01200 | 1.21013598 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 1.18885631 |
| 45 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.16407064 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13619585 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.12634957 |
| 48 | Lysine degradation_Homo sapiens_hsa00310 | 1.06253488 |
| 49 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.04851337 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.03569313 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.03520464 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98505946 |
| 53 | Malaria_Homo sapiens_hsa05144 | 0.96437027 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.93933664 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89651422 |
| 56 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.87106728 |
| 57 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83380317 |
| 58 | Renin secretion_Homo sapiens_hsa04924 | 0.82595411 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82525543 |
| 60 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.81284643 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79551100 |
| 62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.79077386 |
| 63 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.78816875 |
| 64 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.78433507 |
| 65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78135625 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.77328613 |
| 67 | Mineral absorption_Homo sapiens_hsa04978 | 0.77271553 |
| 68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.75735386 |
| 69 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.73182143 |
| 70 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.72671335 |
| 71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72219278 |
| 72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.70675830 |
| 73 | Lysosome_Homo sapiens_hsa04142 | 0.70275982 |
| 74 | Focal adhesion_Homo sapiens_hsa04510 | 0.70000253 |
| 75 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69612286 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69318294 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67817143 |
| 78 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63941452 |
| 79 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.63829805 |
| 80 | Tight junction_Homo sapiens_hsa04530 | 0.63469524 |
| 81 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.63326428 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.63306598 |
| 83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62932982 |
| 84 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.61608670 |
| 85 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.58540985 |
| 86 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.57459096 |
| 87 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55773233 |
| 88 | Sulfur relay system_Homo sapiens_hsa04122 | 0.53787685 |
| 89 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.51731918 |
| 90 | Circadian rhythm_Homo sapiens_hsa04710 | 0.49837425 |
| 91 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49521288 |
| 92 | Axon guidance_Homo sapiens_hsa04360 | 0.46867464 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46691901 |
| 94 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.45388718 |
| 95 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.42768215 |
| 96 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42253158 |
| 97 | Bladder cancer_Homo sapiens_hsa05219 | 0.38298971 |
| 98 | Adherens junction_Homo sapiens_hsa04520 | 0.37816552 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.37354956 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37170127 |
| 101 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.35924386 |
| 102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35415335 |
| 103 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35135121 |
| 104 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.34501576 |
| 105 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.32898415 |
| 106 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.32459060 |
| 107 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.32198595 |
| 108 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.32083269 |
| 109 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.31791312 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31034739 |
| 111 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.30923570 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.29960584 |
| 113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.29679996 |
| 114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.29146923 |
| 115 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.28632880 |
| 116 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.28201332 |
| 117 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.27746430 |
| 118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26255384 |
| 119 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.25710602 |
| 120 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.24901412 |
| 121 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.24001870 |
| 122 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.20039107 |
| 123 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.19781102 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19439809 |
| 125 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.19296492 |
| 126 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.19120150 |
| 127 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.19085124 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.17581176 |

